Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page version was updated from v3.6.2 to v3.6.3, indicating a minor update to the page. There are no visible changes to the study content or data reflected in the provided information.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page's Revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page. This update affects only the version label displayed on the page and does not modify its content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now indicates that recruitment is closed (no longer looking for participants). New help and navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study), and a UI revision note (Revision: v3.6.0) has been introduced.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a small template or software update.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision tag v3.5.4 was added and the previous v3.5.3 tag removed, updating the page's revision history shown in the footer. This reflects a newer update of the page rather than a change to the study data or content.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page’s footer has been updated to reflect a new platform version (Revision v3.5.3 instead of v3.5.2). This is a routine site/version change that does not change the study details shown on the page.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.